Antibody Testing Market is expected to reach US$ 10,740.69 million in 2027

by Sameer Joshi or 10-Feb-2021
Request For Sample

Report : Antibody Testing Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product (Kits, Chemical and Reagents, Consumables); Indication (Pregnancy, Cardiovascular Diseases, Autoimmune Diseases, Infectious Diseases, Oncology, Endocrine Diseases, Others); End-User (Hospitals, Academic and Research Institutes, Diagnostic Laboratories, Biopharmaceutical Companies), and Geography.

Growing Preference for Animal Derived Proteins Supplements and Food Products Driving the Antibody Testing Market
According tour new market research study on “Antibody Testing Market t2027 – Global Analysis and Forecast – by product, genetic material and services,” the market is expected treach US$ 10,740.69 million by 2027 from US$ 6,415.90 million in 2019. The market is estimated tgrow with a CAGR of 6.7% from 2020 t2027. The report highlights trends prevailing in the market, and drivers and hindrances pertaining tthe market growth.
Factors such as rising number of covid-19 cases worldwide, increasing prevalence of chronic diseases and growing geriatric population are expected tboost the growth of the global Antibody Testing market. However, the market is likely tget impacted by the limitations of antibody screening tests during the forecast period.

Antibodies are immunoglobulins, Y-shaped proteins that are produced by the immune system thelp stop intruders from harming the body. An antibody test is a screening for the presence of antibodies in the blood. The body makes antibodies when it fights infection, like COVID-19 or when patients get a vaccine, like a flu shot. That’s how immunity ta virus is built. These tests are alscalled serology tests.
Ever since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared a public health emergency of international concern in late January 2020, medical professionals and researchers have been urging the need for comprehensive and rapid testing of citizens tplan measures that can contain the spread of the virus. Over time, real-time polymerase chain reaction tests and antibody tests have emerged as vital techniques for the global healthcare system tmanage the outbreak. Antibody detection is essential for differential diagnosis of SARS-CoV-2. It is a test performed by patient serum or plasma with reagent red cells. Determination of specific antibodies tviral and bacterial pathogens and parasites facilitates the correct therapeutic measures tbe taken. Antibody testing is critical for implementing an effective and efficient public health strategy tminimize the adverse impact of the COVID-19 pandemic. It should be adopted for important clinical utility cases and support return-to-work strategy globally. 
COVID-19 pandemic has become the most significant challenge across the world. This challenge will be frightening especially in developing countries across the globe as it will lead treducing imports due tdisruptions in global trade. Till date ndefinitive treatment against COVID 19 has been established. Hence, lack of definitive therapy offers significant opportunities for antibody testing market as US FDA has recently approved use of plasma therapy for critically ill COVID 19 patients. In long run Antibody Testing market will have significant growth prospects as many market players has received emergency use authorization for their newly developed antibody tests. All such developments will add up tthe future demand for antibody testing market. 
ThermFisher Scientific, Abbott Laboratories, Bio-Rad Laboratories, Inc., Beckton, Dickinson And Company, F. Hoffmann La Roche, Agilent Technologies, DiaSorin, Zeus Scientific, ABCAM, Trinity Biotech are among the leading companies operating in the antibody testing market.  
The Report Segments Global Antibody Testing Market as follows:
By Product
  • Kits, 
  • Chemical and Reagents, 
  • Consumables
By Indication 
  • Pregnancy, 
  • Cardiovascular Diseases, 
  • Autoimmune Diseases, 
  • Infectious Diseases, 
  • Oncology, 
  • Endocrine Diseases, 
  • Others
By End User
  • Hospitals, 
  • Academic and Research Institutes, 
  • Diagnostic Laboratories, 
  • Biopharmaceutical Companies 
By Geography
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of the Europe
  • Asia Pacific(APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East and Africa
  • South America (SAM)
    • Brazil
    • Argentina 
    • Rest of South America 
Contact Us
Contact Person: Sameer Joshi 
Phone: +1-646-491-9876
Email Id: